Study to Assess PK, Safety and Tolerability in Patients With DM and CKD
Status:
Completed
Trial end date:
2019-07-21
Target enrollment:
Participant gender:
Summary
An open-label, phase IB, multi-center study evaluating DM199 in subjects with Type 1 Diabetes
or Type 2 Diabetes and Stage 3 or 4 Chronic Kidney Disease. The primary objectives of this
study are to evaluate safety, tolerability, and PK profile of DM199 in these subjects.